Seattle Genetics | SGEN - Operating Expenses

Name: Seattle Genetics | SGEN - Operating Expenses
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Seattle,Genetics,SGEN,Operating,Expenses,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Seattle Genetics

Seattle Genetics reported $704.23M in Operating Expenses for its fiscal quarter ending in March of 2023.

	Operating Expenses		Date
AbbVie ABBV:US	USD 9.46B	162M	Mar/2023
Acadia Pharmaceuticals ACAD:US	USD 172.05M	10.51M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD 96.22M	120.59M	Mar/2023
Amgen AMGN:US	USD 4.07B	538M	Mar/2023
Astellas Pharma 4503:JP	JPY 402.5B	61.71B	Mar/2023
Bayer BAYN:GR	EUR 11.42B	848M	Mar/2023
Biogen BIIB:US	USD 1.96B	111.2M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 537.07M	24.97M	Mar/2023
Bluebird Bio BLUE:US	USD -6056000	19.32M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 8.24B	1.22B	Mar/2023
Celldex Therapeutics CLDX:US	USD 33.44M	3.94M	Mar/2023
Daiichi Sankyo 4568:JP	JPY 336.75B	27.83B	Mar/2023
Eisai 4523:JP	JPY 171.99B	7.01B	Mar/2023
Eli Lilly LLY:US	USD 5.47B	600K	Mar/2023
Esperion Therapeutics ESPR:US	USD 72.93M	11.6M	Mar/2023
Exelixis EXEL:US	USD 379.96M	92.04M	Mar/2023
Genmab GEN:DC	DKK 2.42B	145M	Mar/2023
Gilead Sciences GILD:US	USD 4.65B	475M	Mar/2023
GlaxoSmithKline GSK:LN	GBP 4.87B	640M	Mar/2023
Glaxosmithkline GSK:US	GBP 4.87B	640M	Mar/2023
Immunogen IMGN:US	USD 92.26M	8.46M	Mar/2023
Incyte Corp INCY:US	USD 783.9M	72.7M	Mar/2023
Insmed INSM:US	USD 213.37M	2.6M	Mar/2023
Karyopharm Therapeutics KPTI:US	USD 69.6M	2.15M	Mar/2023
MacroGenics MGNX:US	USD 62.92M	1.81M	Mar/2023
Merck & Co MRK:US	USD 10.76B	371M	Mar/2023
Mirati Therapeutics MRTX:US	USD 200.99M	11.67M	Mar/2023
Moderna Inc MRNA:US	USD 2.23B	1.28B	Mar/2023
Nektar Therapeutics NKTR:US	USD 156.3M	81.81M	Mar/2023
Novartis NOVN:VX	USD 10.35B	700M	Mar/2023
Pfizer PFE:US	USD 11.5B	7.63B	Mar/2023
Puma Biotechnology PBYI:US	USD 48.41M	19.61M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 2.22B	52.2M	Mar/2023
Sarepta Therapeutics SRPT:US	USD 778.92M	411.08M	Mar/2023
Seattle Genetics SGEN:US	USD 704.23M	22.08M	Mar/2023
Spectrum Pharmaceuticals SPPI:US	USD 20.48M	1.27M	Mar/2023
Takeda 4502:JP	JPY 867.59B	81.97B	Mar/2023
Teva Pharmaceutical Industries Ltd TEVA:IT	USD 3.66B	1.08B	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 1.6B	326.6M	Mar/2023
Xencor XNCR:US	USD 78.33M	14.02M	Mar/2023